CEO changes
Chief executive officer appointments and departures from SEC 8-K filings.
Updated Nov 6, 2026
CEO changes, last 12 months
380
Appointments
210
Departures
27
Other roles
Get new CEO changes by email
Appointments and departures per month
December 2025 to November 2026
| Month | Appointments | Departures |
|---|---|---|
| December 2025 | 0 | 0 |
| January 2026 | 0 | 0 |
| February 2026 | 0 | 0 |
| March 2026 | 0 | 0 |
| April 2026 | 0 | 0 |
| May 2026 | 0 | 0 |
| June 2026 | 0 | 0 |
| July 2026 | 0 | 0 |
| August 2026 | 59 | 12 |
| September 2026 | 67 | 6 |
| October 2026 | 59 | 4 |
| November 2026 | 25 | 5 |
Sectors with the most CEO changes
Last 12 months
| Sector | CEO changes |
|---|---|
| Software | 24 |
| Biotechnology | 12 |
| Energy | 7 |
| Professional services | 6 |
| Banking and finance | 5 |
| Electronics | 4 |
| Insurance | 3 |
| Restaurants | 3 |
| Health care | 1 |
Filters
380 changes
| Filing date | Company | Person | Change | Effective date | Source |
|---|---|---|---|---|---|
| Nov 2, 2026 | Fluence Energy, Inc. | Julian Nebreda | Departed | Oct 30, 2026 | SEC 8-K |
| Nov 2, 2026 | Fluence Energy, Inc. | Axel Meier | Appointed | Nov 2, 2026 | SEC 8-K |
| Nov 2, 2026 | Supernus, Inc. | Jack A. Khattar | Appointed | Nov 2, 2026 | SEC 8-K |
| Nov 2, 2026 | TELOS CORP | Mark D. Griffin | Appointed | Nov 2, 2026 | SEC 8-K |
| Oct 30, 2026 | American Fusion, Inc. | Richard C. Hawkins | Departed | Oct 26, 2026 | SEC 8-K |
| Oct 30, 2026 | American Fusion, Inc. | Brent Nelson | Appointed | Oct 26, 2026 | SEC 8-K |
| Oct 30, 2026 | BioXcel Therapeutics, Inc. | Vimal Mehta, Ph.D. | Departed | Oct 31, 2026 | SEC 8-K |
| Oct 30, 2026 | EQUITY LIFESTYLE PROPERTIES INC | Patrick Waite | Appointed | Jan 1, 2027 | SEC 8-K |
| Oct 30, 2026 | GENWORTH FINANCIAL INC | Jerome T. Upton | Appointed | Jan 1, 2027 | SEC 8-K |
| Oct 30, 2026 | Zoned Properties, Inc. | Bryan McLaren | Departed | Oct 30, 2026 | SEC 8-K |
| Oct 29, 2026 | CLOROX CO /DE/ | Fabian Garcia | Appointed | Jan 5, 2027 | SEC 8-K |
| Oct 29, 2026 | CLOROX CO /DE/ | Linda Rendle | Departed | Jan 5, 2027 | SEC 8-K |
| Oct 29, 2026 | Estrella Immunopharma, Inc. | Cynthia Pussinen | Appointed | Oct 25, 2026 | SEC 8-K |
| Oct 29, 2026 | Shutterstock, Inc. | Jonathan Oringer | Appointed | Oct 28, 2026 | SEC 8-K |
| Oct 28, 2026 | ALIGN TECHNOLOGY INC | Jennifer L. Davis | Appointed | Nov 2, 2026 | SEC 8-K |
| Oct 28, 2026 | ALIGN TECHNOLOGY INC | Joseph M. Hogan | Departed | Dec 31, 2026 | SEC 8-K |
| Oct 28, 2026 | Azora Therapeutics, Inc. (DE) | Matthew Davidson, Ph.D. | Appointed | Oct 28, 2026 | SEC 8-K |
| Oct 28, 2026 | Azora Therapeutics, Inc. (DE) | Cary J. Claiborne | Departed | Oct 28, 2026 | SEC 8-K |
| Oct 28, 2026 | ENANTA PHARMACEUTICALS INC | Jay R. Luly, Ph.D. | Departed | Feb 1, 2027 | SEC 8-K |
| Oct 28, 2026 | GE HealthCare Technologies Inc. | Jeannette Bankes | Departed | Nov 15, 2026 | SEC 8-K |
Sort:Filing date ↓Company
- Fluence Energy, Inc.Departed
Julian Nebreda CEO
Filed Nov 2, 2026Effective Oct 30, 2026SEC 8-K
- Fluence Energy, Inc.Appointed
Axel Meier CEO
Filed Nov 2, 2026Effective Nov 2, 2026SEC 8-K
- Supernus, Inc.Appointed
Jack A. Khattar CEO
Filed Nov 2, 2026Effective Nov 2, 2026SEC 8-K
- TELOS CORPAppointed
Mark D. Griffin CEO
Filed Nov 2, 2026Effective Nov 2, 2026SEC 8-K
- American Fusion, Inc.Departed
Richard C. Hawkins CEO
Filed Oct 30, 2026Effective Oct 26, 2026SEC 8-K
- American Fusion, Inc.Appointed
Brent Nelson CEO
Filed Oct 30, 2026Effective Oct 26, 2026SEC 8-K
- BioXcel Therapeutics, Inc.Departed
Vimal Mehta, Ph.D. CEO
Filed Oct 30, 2026Effective Oct 31, 2026SEC 8-K
- EQUITY LIFESTYLE PROPERTIES INCAppointed
Patrick Waite CEO
Filed Oct 30, 2026Effective Jan 1, 2027SEC 8-K
- GENWORTH FINANCIAL INCAppointed
Jerome T. Upton CEO
Filed Oct 30, 2026Effective Jan 1, 2027SEC 8-K
- Zoned Properties, Inc.Departed
Bryan McLaren CEO
Filed Oct 30, 2026Effective Oct 30, 2026SEC 8-K
- CLOROX CO /DE/Appointed
Fabian Garcia CEO
Filed Oct 29, 2026Effective Jan 5, 2027SEC 8-K
- CLOROX CO /DE/Departed
Linda Rendle CEO
Filed Oct 29, 2026Effective Jan 5, 2027SEC 8-K
- Estrella Immunopharma, Inc.Appointed
Cynthia Pussinen CEO
Filed Oct 29, 2026Effective Oct 25, 2026SEC 8-K
- Shutterstock, Inc.Appointed
Jonathan Oringer CEO
Filed Oct 29, 2026Effective Oct 28, 2026SEC 8-K
- ALIGN TECHNOLOGY INCAppointed
Jennifer L. Davis CEO
Filed Oct 28, 2026Effective Nov 2, 2026SEC 8-K
- ALIGN TECHNOLOGY INCDeparted
Joseph M. Hogan CEO
Filed Oct 28, 2026Effective Dec 31, 2026SEC 8-K
- Azora Therapeutics, Inc. (DE)Appointed
Matthew Davidson, Ph.D. CEO
Filed Oct 28, 2026Effective Oct 28, 2026SEC 8-K
- Azora Therapeutics, Inc. (DE)Departed
Cary J. Claiborne CEO
Filed Oct 28, 2026Effective Oct 28, 2026SEC 8-K
- ENANTA PHARMACEUTICALS INCDeparted
Jay R. Luly, Ph.D. CEO
Filed Oct 28, 2026Effective Feb 1, 2027SEC 8-K
- GE HealthCare Technologies Inc.Departed
Jeannette Bankes CEO
Filed Oct 28, 2026Effective Nov 15, 2026SEC 8-K